Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
TNM stage still serves as the best prognostic marker in gastric cancer (GC). The next step is to find prognostic biomarkers that detect subgroups with different prognoses in the same TNM stage. In this study, the expression levels of epidermal growth factor receptor (EGFR) and cyclin D1 were assesse...
Main Authors: | Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/44/3/93 |
Similar Items
-
Cyclin C: A new responser for chemosensitivity in cancer
by: Shuai Fang, et al.
Published: (2022-04-01) -
The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
by: Aadil Javed, et al.
Published: (2023-02-01) -
Clinical study of the posterior gastric artery and the lymph nodes around it in patients with gastric cancer
by: Kexin Wang, et al.
Published: (2024-04-01) -
Targeted microRNA Profiling in Gastric Cancer with Clinical Assessement
by: Pehlevan Özel H, et al.
Published: (2022-06-01) -
Gastric cancer screening – does it exist or not? – Literature review
by: Maria Karolina Kalicka, et al.
Published: (2021-10-01)